Press Release: Adapt Introduces Advanced Deep TMS Therapy in Western New York

FOR IMMEDIATE RELEASE

Buffalo, NY - [July 8th, 2024] - Adapt Psychiatry proudly announces the introduction of Deep Transcranial Magnetic Stimulation (Deep TMS) therapy, becoming the first and only provider in Western New York to offer this innovative treatment. This advanced therapy is made possible through Adapt's strategic partnership with BrainsWay, the leading developer of Deep TMS technology.

Deep TMS is FDA-cleared for treating major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), offering hope for patients who have not responded to traditional treatments. Utilizing BrainsWay's patented H-Coil technology, Deep TMS provides deeper and broader brain stimulation, leading to higher efficacy and better patient outcomes.

"We are excited to bring this cutting-edge treatment to our community," said Dr. Peter Margulis, consulting psychiatrist at Adapt Psychiatry. "Our partnership with BrainsWay allows us to offer a new level of care for patients struggling with treatment resistant depression and OCD."

Deep TMS therapy at Adapt Psychiatry is non-invasive, comfortable, and integrates seamlessly into patients' daily lives. With minimal side effects and no need for anesthesia, patients can resume their regular activities immediately after each session.

For more information or to schedule a consultation, please visit Adapt's TMS Page or schedule a consultation by visiting the Adapt Scheduling App.

Contact Information: Tanvir Shagar

Executive Director

Phone: 716-929-6888 Email: TShagar@adaptwny.com

Address: 273 Ridge Road, Buffalo, NY 14218